PCP
LGND icon

Perimeter Capital Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Perimeter Capital Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,709
Closed -$255K – 17
2014
Q3 		$255K Sell
8,709
-32,632
-79% -$1.08M 0.43% 58
2014
Q2 		$1.61M Buy
41,341
+4,055
+11% +$165K 0.82% 28
2014
Q1 		$1.56M Sell
37,286
-6,332
-15% -$264K 0.78% 39
2013
Q4 		$1.43M Buy
43,618
+424
+1% +$13.8K 0.7% 54
2013
Q3 		$1.17M Buy
+43,194
New +$1.22M 0.22% 153

Other funds holding LGND

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return